Influence of arginines 93, 97, and 101 of thrombin to its functional specificity

被引:40
作者
He, XH
Ye, J
Esmon, CT
Rezaie, AR
机构
[1] OKLAHOMA MED RES FDN,CARDIOVASC BIOL RES PROGRAM,OKLAHOMA CITY,OK 73104
[2] UNIV OKLAHOMA,HLTH SCI CTR,DEPT PATHOL,OKLAHOMA CITY,OK 73104
[3] UNIV OKLAHOMA,HLTH SCI CTR,DEPT BIOCHEM,OKLAHOMA CITY,OK 73104
[4] UNIV OKLAHOMA,HLTH SCI CTR,DEPT MOL BIOL,OKLAHOMA CITY,OK 73104
[5] UNIV OKLAHOMA,HLTH SCI CTR,HOWARD HUGHES MED INST,OKLAHOMA CITY,OK 73104
关键词
D O I
10.1021/bi9704717
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutation of three Arg residues, 93, 97, and 101, to Ala in thrombin (thrombin R93,97,101A) has previously been shown to eliminate most heparin acceleration of thrombin inhibition by antithrombin and most of the ability of chondroitin sulfate (CS) on thrombomodulin (TM) to enhance affinity for TM and to eliminate the characteristic high-affinity interaction with protein C observed with TM lacking CS. In this study we examined the relative impact of mutation of these Arg residues alone and in combination on the above reactions and, in addition, on the ability of rabbit TM to accelerate thrombin inhibition by antithrombin. The order of importance for heparin acceleration of inhibition by antithrombin was Arg 101, 93, and 97. In contrast, Arg 97 was the major residue required for TM-dependent acceleration of reactivity with antithrombin and for CS-dependent enhancement of TM affinity. Arg 101 and 93 were critical for TM-dependent, high-affinity protein C interaction at low Ca2+ concentrations, while Arg 97, which was critical for the other TM-dependent effects, played no detectable role in this metal dependence. These results illustrate that these Arg residues in anion binding exosite 2 contribute very differently to the diverse reactions dependent on that domain in thrombin.
引用
收藏
页码:8969 / 8976
页数:8
相关论文
共 42 条
[1]   STRUCTURES OF THE NONCOVALENT COMPLEXES OF HUMAN AND BOVINE PROTHROMBIN FRAGMENT-2 WITH HUMAN PPACK-THROMBIN [J].
ARNI, RK ;
PADMANABHAN, K ;
PADMANABHAN, KP ;
WU, TP ;
TULINSKY, A .
BIOCHEMISTRY, 1993, 32 (18) :4727-4737
[2]   THE REFINED 1.9 A CRYSTAL-STRUCTURE OF HUMAN ALPHA-THROMBIN - INTERACTION WITH D-PHE-PRO-ARG CHLOROMETHYLKETONE AND SIGNIFICANCE OF THE TYR-PRO-PRO-TRP INSERTION SEGMENT [J].
BODE, W ;
MAYR, I ;
BAUMANN, U ;
HUBER, R ;
STONE, SR ;
HOFSTEENGE, J .
EMBO JOURNAL, 1989, 8 (11) :3467-3475
[3]  
BODE W, 1992, PROTEIN SCI, V1, P426
[4]   GLYCOSAMINOGLYCANS AND THE REGULATION OF BLOOD-COAGULATION [J].
BOURIN, MC ;
LINDAHL, U .
BIOCHEMICAL JOURNAL, 1993, 289 :313-330
[5]  
CHURCH FC, 1989, J BIOL CHEM, V264, P18419
[6]  
DITTMAN WA, 1990, BLOOD, V75, P329
[7]  
ESMON CT, 1993, METHOD ENZYMOL, V222, P359
[8]   THROMBOMODULIN AS A MODEL OF MOLECULAR MECHANISMS THAT MODULATE PROTEASE SPECIFICITY AND FUNCTION AT THE VESSEL SURFACE [J].
ESMON, CT .
FASEB JOURNAL, 1995, 9 (10) :946-955
[9]   Involvement of thrombin anion-binding exosites 1 and 2 in the activation of factor V and factor VIII [J].
Esmon, CT ;
Lollar, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (23) :13882-13887
[10]  
GALVIN JB, 1987, J BIOL CHEM, V262, P2199